Navigation Links
Sitagliptin, Under Investigation For Type 2 Diabetes

The number of people suffering from diabetes is already over 194 million worldwide and the number is expected to increase by 333 million by 2025. Type II diabetes is also known as non-insulin dependent diabetes // and is characterized by a relative disparity between endogenous insulin production and insulin requirements, leading to an elevated glucose. In contrast to Type I diabetes, there is always some endogenous insulin production, and many patients have normal or even elevated blood insulin levels. The disease usually occurs over the age of 40 and treatment involves diet, oral hypoglycemic drugs and exogenous insulin.

However, side effect profile of the given medication, route of administration or difficulties in sustaining glucose control pose serious concerns and necessitate more tolerable treatments that do not cause weight gain and produce less risk of hypoglycemia for patients with type 2 diabetes.

Clinical phase II studies involving Sitagliptin, an investigational diabetes drug, appears to control blood sugar with a low incidence of hypoglycaemia and with a neutral effect on body weight.

Sitagliptin is expected to lower blood glucose levels by increasing the level of active incretin hormones which increase insulin from pancreatic beta-cells and decrease glucagon from pancreatic alpha cells in a glucose-dependent manner (when blood glucose is elevated and not when blood glucose is low). If approved, Sitagliptin would be a member of a new class of antihyperglycaemic agents called DPP-IV inhibitors, which inhibit the DPP-4 enzyme that normally inactivates the incretin gut hormones GLP-1 and GIP. The patients studied exhibited a safety and tolerability profile similar to placebo. In addition, patients taking Sitagliptin experienced no significant weight gain and a low risk of hypoglycaemia. Patients treated with glipizide had an average weight gain of 1.1 kilogram relative to placebo. Adverse event reports of hypoglycaemia were
'"/>




Page: 1 2

Related medicine news :

1. Undertaking the obesity epidemic
2. Breast Cancer in Men Often Underestimated and Under-treated
3. Drug to Lower Cholesterol Underused
4. Understanding The Predictors Of Prostate Cancer
5. Understanding Restless Legs Syndrome
6. Understanding Lung Cancer Metastasis
7. Understanding The Link Between Hormone Replacement and Respiratory Disease
8. Understanding The Risks Of Hormone Therapy
9. Understanding The Link Between Metabolic Syndrome And Drinking Patterns
10. A Better Understanding Of The Brain Network
11. Understanding The Predictor’s Of Alzheimer’s Diseae
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Sitagliptin Under Investigation For Type Diabetes

(Date:9/20/2014)... Lifeinsurancequoteterm.net has released a new ... exam life insurance plan provides for vulnerable family members. ... should be a top priority for every provider. It ... taking medical examinations and visiting a doctor. , ... will provide coverage up to $300,000, but only to ...
(Date:9/20/2014)... The festival season is coming soon. The high-end fashion ... cocktail dresses . A lot of sophisticated women like ... a new promotion for its high quality clothes. Now, each ... from 20 to 71 percent off. , The company’s ... are provided in many fashionable colors. Mary, the company’s sales ...
(Date:9/20/2014)... September 20, 2014 As concerns ... ) in gynecological surgeries continue to grow, ... has announced plans to end coverage for uterine ... website last month, Harrisburg, Pennsylvania-based Capital BlueCross will ... 2014. The insurer said its decision was prompted ...
(Date:9/20/2014)... The excitement is building up once again for ... This year the Surry Arts Council will be celebrating its ... country who are still fans of the Andy Griffith Show. ... aired on CBS from 1960 through 1968. The show ranked ... history. Mount Airy, North Carolina is where the show was ...
(Date:9/20/2014)... 2014 Recently, UWDress.com, an innovative company ... special occasion outfits, has launched a special offer for ... outfits are popular among worldwide clients. Now, all the ... prom dresses on its website. , Additionally, the ... around the world. Great custom made items can be ...
Breaking Medicine News(10 mins):Health News:No Medical Exam Life Insurance Provides Financial Protection for Families 2Health News:High-end Fashion Designer BellasDress Offers Luxurious Cocktail Dresses For Sophisticated Women 2Health News:As Power Morcellator Concerns Grow, Bernstein Liebhard LLP Notes Another Insurer’s Decision to Drop Coverage for Uterine Morcellation 2Health News:As Power Morcellator Concerns Grow, Bernstein Liebhard LLP Notes Another Insurer’s Decision to Drop Coverage for Uterine Morcellation 3Health News:Mayberry Days Parade Cars will be Provided by Mount Airy Toyota and Mount Airy Chrysler Dodge Jeep Ram 2Health News:Discounted 2014 Prom Dresses Provided By Innovative Company UWDress.com 2
... treatments, help may be right around the corner . A ... gain back their fertility -- even after going into menopause ... cause a woman to experience premature menopause and diminish her ... froze a 30-year-old woman’s ovarian tissue to determine if they ...
... United States, is linked to obesity and lack of exercise. It ... properly to metabolize food, especially sugar. Type-I or juvenile diabetes is ... ,In a recent study of 14,600 people, it was ... had nearly an 80 percent lowered risk, while men who drank ...
... the estrogen pills do not reduce the risk of heart ... ,Researchers say their results show estrogen alone does ... disease as combination hormone therapy is believed to do. Estrogen ... developing breast cancer. Researchers say the hormone does appear to ...
... new study shows eating dietary fiber specifically from fruits ... research has suggested // a connection between higher intake ... few studies have actually looked at the dietary fiber ... In a recent study researchers analyzed several studies to ...
... Being overweight in childhood can no longer be considered ... Recent study shows nearly 60 percent of overweight children ... ,The prevalence of type 2 diabetes is increasing ... the epidemic of type 2 diabetes in developing countries ...
... in the United States annually, and of these, 20 ... cell lung carcinoma (SCLC). Prognosis for these patients is ... and central nervous system. ,The probability of developing ... Whether or not these brain metastases directly impact mortality ...
Cached Medicine News:Health News:Childhood Weight Gain Found To Increase The Risk of Diabetes 2
(Date:9/19/2014)... Tenn. , Sept. 19, 2014  Over 200 ... the Future to Benefit the Radiation Oncology Institute (ROI), ... held at Golden Gate Park in San Francisco.  ... Dan Moore , CEO of Radiation Business Solutions, ... we have raised over $70,000 for the ROI this ...
(Date:9/19/2014)... CAMBRIDGE, Mass. , Sept. 19, 2014 ... a provider of advanced cancer genome analysis and ... leader in discovering and developing highly selective kinase ... first-ever comprehensive genomic study of malignant mixed Mullerian ... the female reproductive system, also known as carcinosarcoma. ...
(Date:9/18/2014)... ... announced the addition of the "Global ... their offering.      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) ... chromosomes using molecular biology to understand the ... It plays a crucial role in the ...
Breaking Medicine Technology:Fifth Annual 5K Run for the Future to Benefit the Radiation Oncology Institute Breaks Attendance, Donation Records 2Fifth Annual 5K Run for the Future to Benefit the Radiation Oncology Institute Breaks Attendance, Donation Records 3First Discovery Of Actionable Genetic Alterations In A Deadly Cancer Reported By Personal Genome Diagnostics And Blueprint Medicines 2First Discovery Of Actionable Genetic Alterations In A Deadly Cancer Reported By Personal Genome Diagnostics And Blueprint Medicines 3First Discovery Of Actionable Genetic Alterations In A Deadly Cancer Reported By Personal Genome Diagnostics And Blueprint Medicines 4Global Molecular Cytogenetics Market 2014-2018: Key Vendors are Abbott, Affymetrix, Agilent Technologies, F. Hoffmann-La Roche, Illumina and PerkinElmer 2Global Molecular Cytogenetics Market 2014-2018: Key Vendors are Abbott, Affymetrix, Agilent Technologies, F. Hoffmann-La Roche, Illumina and PerkinElmer 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: